LINC-ROR and breast carcinoma: Previous studies unveiled that linc-ROR could act as a p53 repressor in response to DNA damage, and the knockdown of linc-RoR leads to a modest increase in apoptosis and activation of p53 pathways [20, 49], which may contribute to breast cancer tumourigenesis and metastasis.